Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

PKCβ inhibitor

DRUG CLASS:

PKCβ inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

enzastaurin (3)

Z-endoxifen (1)

enzastaurin (3)

Z-endoxifen (1)

›

No biomarker	Glioblastoma	No biomarker	Glioblastoma	enzastaurin Sensitive: B - Late Trials enzastaurin Sensitive : B	enzastaurin Sensitive: B - Late Trials enzastaurin Sensitive : B
GNAQ Q209P	Uveal Melanoma	GNAQ Q209P	Uveal Melanoma	enzastaurin Sensitive: D – Preclinical enzastaurin Sensitive : D	enzastaurin Sensitive: D – Preclinical enzastaurin Sensitive : D
GNAQ Q209L	Uveal Melanoma	GNAQ Q209L	Uveal Melanoma	enzastaurin Sensitive: D – Preclinical enzastaurin Sensitive : D	enzastaurin Sensitive: D – Preclinical enzastaurin Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	doxorubicin hydrochloride + Z-endoxifen Sensitive: D – Preclinical doxorubicin hydrochloride + Z-endoxifen Sensitive : D	doxorubicin hydrochloride + Z-endoxifen Sensitive: D – Preclinical doxorubicin hydrochloride + Z-endoxifen Sensitive : D